Hiteck(SZ:300683) Zheng Xing Xing Ye Ri Bao·2025-08-21 08:30Market Overview - On August 21, the medical services sector declined by 0.15%, with Haitai Biological leading the drop [1] - The Shanghai Composite Index closed at 3771.1, up 0.13%, while the Shenzhen Component Index closed at 11919.76, down 0.06% [1] Stock Performance - Notable gainers in the medical services sector included: - Bid Medicine (688073) with a closing price of 63.23, up 5.31% on a trading volume of 20,200 shares and a turnover of 124 million yuan [1] - Chengda Pharmaceutical (301201) closed at 31.40, up 3.90% with a trading volume of 84,300 shares and a turnover of 266 million yuan [1] - Aoyang Health (002172) closed at 4.44, up 3.74% with a trading volume of 829,800 shares and a turnover of 368 million yuan [1] - Major decliners included: - Haitai Biological (300683) closed at 50.73, down 4.17% with a trading volume of 78,000 shares and a turnover of 404 million yuan [2] - Sanbo Brain Science (301293) closed at 61.25, down 3.88% with a trading volume of 164,100 shares and a turnover of 1.009 billion yuan [2] - Haochen Medical (002622) closed at 3.83, down 3.28% with a trading volume of 997,600 shares and a turnover of 386 million yuan [2] Capital Flow - The medical services sector experienced a net outflow of 821 million yuan from institutional investors, while retail investors saw a net inflow of 528 million yuan [2][3] - Key stocks with significant capital flow included: - Jinkai Biotechnology (301509) with a net inflow of 57.64 million yuan from institutional investors [3] - Huada Gene (300676) saw a net outflow of 23.72 million yuan from retail investors [3] - Aoyang Health (002172) had a net inflow of 23.03 million yuan from institutional investors [3]